Novavax, Inc [NASDAQ: NVAX] loss -7.68% or -0.54 points to close at $6.49 with a heavy trading volume of 8708762 shares.
The daily chart for NVAX points out that the company has recorded -28.05% loss over the past six months.
If we look at the average trading volume of 8.53M shares, NVAX reached to a volume of 8708762 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Novavax, Inc [NVAX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NVAX shares is $13.43 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NVAX stock is a recommendation set at 2.71. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Novavax, Inc shares, keeping their opinion on the stock as Sell, with their previous recommendation back on June 17, 2025. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on February 28, 2025, representing the official price target for Novavax, Inc stock. Previously, the target price had yet another raise to $8, while JP Morgan analysts kept a Underweight rating on NVAX stock.
The Average True Range (ATR) for Novavax, Inc is set at 0.48, with the Price to Sales ratio for NVAX stock in the period of the last 12 months amounting to 0.84.
Trading performance analysis for NVAX stock
Novavax, Inc [NVAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.86. With this latest performance, NVAX shares dropped by -3.57% in over the last four-week period, additionally sinking by -28.05% over the last 6 months – not to mention a drop of -56.88% in the past year of trading.
#####
Novavax, Inc [NVAX]: A deeper dive into fundamental analysis
Novavax, Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.03 and a Current Ratio set at 2.06.
An analysis of Institutional ownership at Novavax, Inc [NVAX]
The top three institutional holders of NVAX stocks are: VANGUARD GROUP INC with ownership of 14.08 million shares, which is approximately 9.4861%. BLACKROCK INC., holding 11.85 million shares of the stock with an approximate value of $$149.98 million in NVAX stocks shares; and BLACKROCK INC., currently with $$122.32 million in NVAX stock with ownership which is approximately 6.5118%.
